摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-N-carboxybenzyloxy phenylglycinamide | 67861-68-1

中文名称
——
中文别名
——
英文名称
(S)-N-carboxybenzyloxy phenylglycinamide
英文别名
benzyl [(1S)-2-amino-2-oxo-1-phenylethyl]carbamate;Cbz-L-Phg-NH2;Z-L-Phenylglycinamid;Z-L-Phg-NH2;benzyl N-[(1S)-2-amino-2-oxo-1-phenylethyl]carbamate
(S)-N-carboxybenzyloxy phenylglycinamide化学式
CAS
67861-68-1
化学式
C16H16N2O3
mdl
——
分子量
284.315
InChiKey
NTKPNKLUBASDQB-AWEZNQCLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    21
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    81.4
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Dehydration of Chiral α-Amides to Chiral α-Nitriles Under the Appel Reaction Conditions
    作者:Shekharappa、L. Roopesh Kumar、C. Srinivasulu、Vommina V. Sureshbabu
    DOI:10.1007/s10989-020-10101-y
    日期:2021.3
    Nα-protected amino acid amides to corresponding nitriles with neither harsh condition nor catalyst. Graphic Abstract Nα-protected amino acid amides were efficiently transformed to Nα-protected amino acid nitriles employing I2, PPh3, and NMM under mild reaction conditions. Fmoc, Boc and Cbz-protected amino acid amides were converted into their corresponding nitriles groups. Side chain protected amino acid amides
    N的有效的合成α -保护的基腈选自N α -保护的使用pH值基酰胺3 P,I 2和NMM被描述。受Fmoc,Z和Boc保护的各种氨基酸酰胺可方便地以高收率转化为腈。侧链保护的氨基酸酰胺具有良好的耐受性,并获得了良好的产物收率。该协议用作温和的一个,对于N的自由外消旋转换几个可用的,方法中α -保护的氨基酸酰胺与既不苛刻的条件,也没有催化剂相应的腈。 图形摘要 Ñ α -保护的氨基酸酰胺被有效转化成N α采用我-保护氨基酸腈2,PPH 3,和NMM温和的反应条件下进行。Fmoc,Boc和Cbz保护的氨基酸酰胺被转化为相应的腈基。侧链保护的氨基酸酰胺也容易以良好的产率转化为其相应的腈。
  • Phenylglycine-containing new peptides with gastrine effects and a
    申请人:Richter Gedeon Vegyeszeti Gyar Rt.
    公开号:US04183909A1
    公开(公告)日:1980-01-15
    The invention relates to novel peptides of formula (I), A-Try-B-Asp-Phg-NH.sub. 2 (I) wherein A is tert.-butoxycarbonyl-aminooxy-acyl, benzyloxycarbonyl-aminooxy-acyl, (aminooxy)-acyl or E-aminooxy-acyl, wherein E is benzoyl or straight-chained or branched C.sub.1-5 aliphatic acyl, and B represents methionyl, leucyl, norleucyl, norvalyl or 2-amino-decanoyl, or acid addition salts or complexes thereof. The novel compounds according to the invention exert gastrin effects and can be applied to advantage in the diagnostics and therapy. The novel compounds of formula (I) are prepared according to the invention by reacting a tetrapeptideamide of formula (II), H-Try-B-Asp-Phg-NH.sub. 2 (II) wherein B is as defined above, with an (aminooxy)-acyl containing compound of the general formula A.sub.1 -X, wherein A.sub.1 has the same meanings as A with the exception of the (aminooxy)-acyl, and X is hydroxy group, halogen, pivaloyloxy, a group of the formula R--O--CO.sub.2 -- (wherein R is lower alkyl, phenoxy which can have a nitro substituent or one or more halogen or N-succinimidoxy.
    本发明涉及公式(I)的新肽,A-Try-B-Asp-Phg-NH.sub.2(I),其中A是tert.-butoxycarbonyl-aminooxy-acyl,benzyloxycarbonyl-aminooxy-acyl,(aminooxy)-acyl或E-aminooxy-acyl,其中E是苯甲酰基或直链或支链C.sub.1-5脂肪酰基,B代表甲酰基,亮酰基,诺亮酰基,诺缩酰基或2-基癸酰基,或其酸加成盐或络合物。本发明的新化合物具有胃泌素效应,并可优势地应用于诊断和治疗。公式(I)的新化合物是通过将公式(II)的四肽酰胺,H-Try-B-Asp-Phg-NH.sub.2(II),其中B如上所定义,与含有(aminooxy)-acyl的化合物A.sub.1-X反应而制备的,其中A.sub.1除了(aminooxy)-acyl外具有与A相同的含义,X是羟基,卤素,皮瓦酰氧基,公式R-O-CO.sub.2-(其中R是低碳基,苯氧基可以有一个硝基取代基或一个或多个卤素或N-琥珀酰氧基)。
  • KAPPA OPIOID AGONISTS AND USES THEREOF
    申请人:NEKTAR THERAPEUTICS
    公开号:US20160145245A1
    公开(公告)日:2016-05-26
    Provided are compounds of Formula I; and pharmaceutically acceptable salts and solvates thereof. The compounds of Formula I described herein relate to and/or have application(s) in (among others) the fields of drug discovery, pharmacotherapy, physiology, organic chemistry and polymer chemistry.
    提供的是公式I的化合物;以及其药学上可接受的盐和溶剂化合物。本文所描述的公式I的化合物与/或适用于(其中之一)药物发现、药理学、生理学、有机化学和高分子化学等领域。
  • Green diastereospecific synthesis of various medicine analogues containing dipeptides and release of the medicines by Baker's yeast
    作者:Sunghee Jung、Shin Satoh、Hideyuki Daitoku、Takuya Noguchi、Yuya Kawashima、Nobuyuki Imai
    DOI:10.1016/j.tet.2022.133102
    日期:2022.11
    dipeptides in 76–99% yields with 70–>99% de and dipeptides-containing medicine analogues in 74–99% yields with 79–97% de in aqueous THF at −15 °C via the mixed carbonic carboxylic anhydrides by the activation of the corresponding carboxylic acids. We observed that the anilide l-Phe-l-Phe-NHC6H4-4-OH, one of the deprotecting medicine analogues, was cleaved at the C-terminal of l-phenylalanine (l-Phe) by
    我们已经成功地以 76–99% 的收率和 70–>99% 的去氧化酶绿色和经济地合成了各种二肽和含二肽的药物类似物,在 -15 °C 的性 THF 中以 79–97% 的去氧化酶的收率在 -15 °C 下通过通过相应羧酸的活化得到混合碳酸酐。我们观察到苯胺l -Phe- l -Phe-NHC 6 H 4 -4-OH 是一种脱保护药物类似物,在饥饿条件下被贝克酵母在l-苯丙酸 ( l -Phe) 的C端裂解条件,然后处理新鲜制备的 PhCH 2 CH 2 CO 2 CO 2Et 从 3-苯基丙酸、ClCO 2 Et 和 Et 3 N 在 MeCN 中得到 PhCH 2 CH 2 CONHC 6 H 4 -4-OH 和 PhCH 2 CH 2 CO - 1 -Phe-NHC 6 H 4 -4-OH收益率分别为 46% 和 42%。有趣的是,贝克酵母对l -Phe- d -Phe-NHC 6
  • <i>N</i>-Urethane-Protected Amino Alkyl Isothiocyanates: Synthesis, Isolation, Characterization, and Application to the Synthesis of Thioureidopeptides
    作者:Vommina V. Sureshbabu、Shankar A. Naik、H. P. Hemantha、N. Narendra、Ushati Das、Tayur N. Guru Row
    DOI:10.1021/jo900675s
    日期:2009.8.7
    Synthetically useful N-Fmoc amino-alkyl isothiocyanates have been described, starting from protected amino acids. These compounds have been synthesized in excellent yields by thiocarbonylation of the monoprotected 1,2-diamines with CS2/TEA/p-TsCl, isolated as stable solids, and completely characterized. The procedure has been extended to the synthesis of amino alkyl isothiocyanates from Boc- and Z-protected amino acids as well. The utility of these isothiocyanates for peptidomimetics synthesis has been demonstrated by employing them in the preparation of a series of dithioureidopeptide esters. Boc-Gly-OH and Boc-Phe-OH derived isothiocyanates 9a and 9c have been obtained as single crystals and their structures solved through X-ray diffraction. They belong to the orthorhombic crystal system, and have a single molecule in the asymmetric unit (Z' = 1). 9a crystallizes in the centrosymmetric space group Pbca, while 9c crystallizes in the noncentrosymmetric space group P2(1)2(1)2(1).
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫